Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Dean Follmann, Kathleen M. Neuzil, Allison August, Heather Clouting, Gabrielle Fortier, Weiping Deng, Shu Han, Xiaoping Zhao, Brett Leav, Carla Talarico, Bethany Girard, Yamuna D. Paila, Joanne E. Tomassini, Florian Schödel, Rolando Pajon, Honghong Zhou, Rituparna Das, Jacqueline Miller
doi: https://doi.org/10.1101/2021.09.17.21263624
Lindsey R. Baden
1Brigham and Women’s Hospital
M.D.Hana M. El Sahly
2Baylor College of Medicine
M.D.Brandon Essink
3Meridian Clinical Research
M.D.Dean Follmann
4National Institute of Allergy and Infectious Diseases
Ph.D.Kathleen M. Neuzil
5University of Maryland
M.D.Allison August
6Moderna, Inc.
M.D.Heather Clouting
6Moderna, Inc.
MSc.Gabrielle Fortier
6Moderna, Inc.
MPH.Weiping Deng
6Moderna, Inc.
Ph.D.Shu Han
6Moderna, Inc.
Ph.D.Xiaoping Zhao
6Moderna, Inc.
M.S.Brett Leav
6Moderna, Inc.
M.D.Carla Talarico
6Moderna, Inc.
PhDBethany Girard
6Moderna, Inc.
Ph.D.Yamuna D. Paila
6Moderna, Inc.
Ph.D.Joanne E. Tomassini
6Moderna, Inc.
Ph.D.Florian Schödel
6Moderna, Inc.
M.D., Ph.DRolando Pajon
6Moderna, Inc.
Ph.D.Honghong Zhou
6Moderna, Inc.
Ph.D.Rituparna Das
6Moderna, Inc.
M.D., Ph.D.Jacqueline Miller
6Moderna, Inc.
M.D.![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
As the trial is ongoing, access to patient-level data and supporting clinical documents with qualified external researchers may be available upon request and subject to review once the trial is complete.
Posted September 22, 2021.
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Dean Follmann, Kathleen M. Neuzil, Allison August, Heather Clouting, Gabrielle Fortier, Weiping Deng, Shu Han, Xiaoping Zhao, Brett Leav, Carla Talarico, Bethany Girard, Yamuna D. Paila, Joanne E. Tomassini, Florian Schödel, Rolando Pajon, Honghong Zhou, Rituparna Das, Jacqueline Miller
medRxiv 2021.09.17.21263624; doi: https://doi.org/10.1101/2021.09.17.21263624
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Dean Follmann, Kathleen M. Neuzil, Allison August, Heather Clouting, Gabrielle Fortier, Weiping Deng, Shu Han, Xiaoping Zhao, Brett Leav, Carla Talarico, Bethany Girard, Yamuna D. Paila, Joanne E. Tomassini, Florian Schödel, Rolando Pajon, Honghong Zhou, Rituparna Das, Jacqueline Miller
medRxiv 2021.09.17.21263624; doi: https://doi.org/10.1101/2021.09.17.21263624
Subject Area
Subject Areas
- Addiction Medicine (348)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2644)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12218)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4091)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2654)
- Health Policy (1004)
- Hematology (362)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (434)
- Neurology (3872)
- Nursing (209)
- Nutrition (577)
- Oncology (2025)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6520)
- Radiology and Imaging (1400)
- Respiratory Medicine (871)
- Rheumatology (406)
- Sports Medicine (342)
- Surgery (447)
- Toxicology (53)
- Transplantation (185)
- Urology (165)